AUSKIPRA-GN
AUSKIPRA-GN
Authorised
- Aujeszky's disease virus, strain Bartha K61, Live
Product identification
Medicine name:
АУСКИПРА-GN
AUSKIPRA-GN
Active substance:
- Aujeszky's disease virus, strain Bartha K61, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Aujeszky's disease virus, strain Bartha K61, Live5.50/log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate for solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- BFSA
Authorisation number:
- 0022-1577-07.06.2011
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/05/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/05/2022
How useful was this page?:
